Pressure Biosciences Inc (PBIO) Inventory Turnover Ratio, from second quarter 2024 to second quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Pressure Biosciences Inc   (PBIO)
 

Pressure Biosciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Pressure Biosciences Inc inventory turnover ratio, the Pressure Biosciences Inc 's ability to sell and replace its inventory in the second quarter 2024, sequentially increased to 2.46 in the second quarter 2024, PBIO's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Pressure Biosciences Inc in Jun 30 2024 quarter, has decreased to 148 days, compare to 167 days, in the Mar 31 2024 quarter.

Within Healthcare sector 177 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1204 in the first quarter 2024, to 1285.

PBIO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Pressure Biosciences Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PBIO Inventory Turnover Ratio (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Inventory Growth -2.12 % -10.39 % -55.58 % -66.3 % -59.16 %
Y / Y Cost of Sales Growth 47.13 % -34.94 % -73.77 % 81.85 % -15.07 %
Inventory Turnover Ratio (TTM) 2.46 2.19 2.37 3.57 2.45
PBIO's Total Ranking # 1285 # 1204 # 808 # 1257 #
Average inventory processing period 149 167 154 102 149
Seq. Inventory Growth -9.2 % 95.75 % -34.74 % -15.62 % -16.87 %
Seq. Cost of Sales Growth 61.82 % -30.05 % 45.32 % -10.56 % -28.45 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 10
Healthcare Sector # 178
Overall Market # 1285

Inventory Turnover Ratio Statistics
High Average Low
3.57 1.19 0.09
(Sep 30 2023)   (Jun 30 2012)



PBIO Company Profile >> Back to PBIO Efficiency Comparisons >> Compare PBIO Inventory Turnover Ratio to its Competitors

Financial Statements
Pressure Biosciences Inc 's Inventories $ 1 Millions Visit PBIO's Balance sheet
Pressure Biosciences Inc 's Cost of Revenues TTM $ 1 Millions Visit PBIO's Income Statement
What are PBIO's Sales? Visit PBIO's Sales by Segment

Other Inventory Turnover Ratios
Pressure Biosciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PBIO's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PBIO's Competitors
Inventory Turnover Ratio for PBIO's Suppliers
Inventory Turnover Ratio for PBIO's Customers

You may also want to know
PBIO's Sales Growth Rates PBIO's Pe Price to earnings ratio PBIO's Receivables Turnover Ratio PBIO's Stock Quote
PBIO's Net Income Growth Rates PBIO's Ps Price to Sales ratio PBIO's Sales per Employee PBIO's Asset Turnover Ratio
PBIO's Net Margin PBIO's Pb Price to Book ratio PBIO's Financial Strength Ratios PBIO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2024 Inventories at quarter ending Jun 30 2024
Cardiff Lexington Corporation  5.95 $ 3.216  Millions$ 1  Millions
Alimera Sciences Inc  5.84 $ 13.568  Millions$ 2  Millions
Twist Bioscience Corporation  5.77 $ 175.573  Millions$ 30  Millions
Veracyte Inc   5.68 $ 98.911  Millions$ 17  Millions
Exact Sciences Corporation  5.59 $ 721.439  Millions$ 129  Millions
Zai Lab Limited  5.52 $ 119.483  Millions$ 22  Millions
Avantor Inc   5.51 $ 4,524.600  Millions$ 821  Millions
Warby Parker Inc   5.43 $ 319.823  Millions$ 59  Millions
Evolus Inc   5.37 $ 71.845  Millions$ 13  Millions
Medinotec Inc   5.20 $ 3.768  Millions$ 1  Millions
Adaptive Biotechnologies Corporation  5.05 $ 76.330  Millions$ 15  Millions
Cryoport inc   5.05 $ 131.114  Millions$ 26  Millions
T2 Biosystems Inc   4.99 $ 23.609  Millions$ 5  Millions
Abbvie Inc   4.95 $ 20,485.000  Millions$ 4,136  Millions
Henry Schein Inc   4.88 $ 8,537.000  Millions$ 1,748  Millions
Integer Holdings Corporation  4.85 $ 1,221.648  Millions$ 252  Millions
Catalent Inc   4.75 $ 3,428.000  Millions$ 722  Millions
Vericel Corporation  4.69 $ 63.450  Millions$ 14  Millions
Prophase Labs Inc   4.65 $ 19.217  Millions$ 4  Millions
Avenir Wellness Solutions Inc   4.60 $ 0.851  Millions$ 0  Millions
Precision Optics Corporation Inc   4.45 $ 13.307  Millions$ 3  Millions
Harrow Inc   4.44 $ 44.461  Millions$ 10  Millions
Adm Tronics Unlimited Inc   4.41 $ 1.748  Millions$ 0  Millions
Scilex Holding Company  4.39 $ 16.143  Millions$ 4  Millions
West Pharmaceutical Services Inc   4.31 $ 1,849.300  Millions$ 429  Millions
Escalon Medical Corp   4.31 $ 6.835  Millions$ 2  Millions
Envista Holdings Corporation  4.31 $ 1,150.700  Millions$ 267  Millions
Steris Plc  4.27 $ 3,085.440  Millions$ 722  Millions
Lifeward ltd   4.25 $ 15.819  Millions$ 4  Millions
Align Technology inc   4.20 $ 1,188.507  Millions$ 283  Millions

Date modified: 2026-09-08T15:11:29+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.